Clearskin

Quick links to important sections

Clearskin

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clearskin

What is Clearskin?

Clearskin is a topical dermatological treatment primarily used for the management of acne vulgaris. It belongs to a class of medications known as retinoids, which are synthetic derivatives of Vitamin A. The formulation is designed to be applied directly to the skin to address various stages of acne development.

Mechanism of Action

The active components in Clearskin work by modulating the biological processes involved in skin cell turnover. It helps to normalize the growth of follicular epithelial cells, which prevents the formation of microcomedones—the precursors to visible acne lesions. By reducing the stickiness of cells within the pores, the treatment facilitates the natural shedding of dead skin and prevents the blockage of sebaceous glands.

Therapeutic Effects

Clearskin is utilized for its ability to target both inflammatory and non-inflammatory acne. Its primary functions include:

  • Comedolytic Activity: It assists in breaking down existing blackheads and whiteheads.
  • Prevention of New Lesions: By maintaining clear pores, it reduces the frequency of new acne outbreaks.
  • Reduction of Inflammation: The medication possesses mild anti-inflammatory properties that can help decrease the redness and swelling associated with acne spots.

Clinical Application

This treatment is typically indicated for patients with mild to moderate acne. It is often used as a long-term maintenance therapy to keep the skin clear once initial inflammation has subsided. Because it influences cell production at the structural level, the effects are usually gradual, requiring consistent application over several weeks to observe visible improvements in skin texture and clarity.

Regulatory References

  1. World Health Organization
  2. WHO Essential List
  3. National Institutes of Health

What side effects are possible with Clearskin?

Possible Side Effects and Safety Information

The official safety profile for Clearskin (Benzoyl Peroxide) primarily details local reactions and systemic hypersensitivity events, as documented in government regulatory sources. Adverse reactions are classified based on frequency and affected body systems.

Adverse Reaction Classifications

The most frequent adverse reactions are related to Skin and Subcutaneous Tissue Disorders and are often seen at the application site. These include:

  • Very Common (Affecting ge 1 in 10 individuals): Skin burning sensation, erythema (redness), dry skin, and skin exfoliation (peeling).
  • Common (Affecting ge 1 in 100 individuals): Pruritus (itching), stinging pain, and generalized skin irritation.

These common local effects are noted to be more likely and tend to peak during the first weeks of treatment and may lessen with continued use.

Serious Adverse Reactions and Safety Constraints

Regulatory documents also detail the potential for rare, but serious, events under Immune System Disorders. These include signs of severe hypersensitivity reactions, such as anaphylaxis or angioedema (swelling of the face, lips, throat, or tongue) and difficulty breathing.

Usage of this medicine is subject to several official safety constraints:

  • It is contraindicated in individuals with a known history of hypersensitivity to benzoyl peroxide.
  • Users must avoid contact with the eyes, mouth, angles of the nose, and mucous membranes due to the risk of severe irritation.
  • The label includes a warning that the product may increase sensitivity to sunlight, and excessive sun exposure should be avoided.

For Pregnancy and Breast-feeding, use is generally advised only if the expected benefit justifies the potential risk, reflecting the limited systemic exposure and adherence to conservative regulatory standards.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Clearskin (Benzoyl Peroxide) is defined by two primary regulatory concerns: severe local toxicity from over-application and rare, serious systemic hypersensitivity reactions.

Documented Overdose Presentations

Overdose from excessive topical use is documented by official sources as non-life-threatening local toxicity. Manifestations include severe skin irritation, characterized by erythema (redness), scaling (peeling), stinging/burning, and local swelling. Systemic physiological compromise is not typically listed as a consequence of topical overdose due to limited absorption.

Conversely, severe systemic hypersensitivity reactions are classified as potentially life-threatening outcomes. These rare reactions, which include anaphylaxis and angioedema, affect the respiratory and cardiovascular systems, presenting with symptoms such as throat tightness, difficulty breathing, and syncope (feeling faint).

Required Emergency Actions

Government regulations mandate immediate action when overdose scenarios occur:

  • Seek immediate medical attention is required for any signs of a severe systemic hypersensitivity reaction, including swelling of the eyes/face/lips/tongue, difficulty breathing, or feeling faint.
  • For symptoms of severe local irritation from over-application, the regulatory instruction is to stop using the product immediately.
  • In cases of accidental ingestion of the product, official instructions require contacting a Poison Control Center right away or obtaining medical help.

Treatment is officially designated as symptomatic and supportive, as no specific antidote is documented for Benzoyl Peroxide toxicity.

Therapeutic Uses of Clearskin

What Clearskin treats: main uses and benefits

Clearskin is commonly used across conditions presenting with acute episodes. It is considered relevant for symptomatic management of acne. The main therapeutic area involves helping with the manifestations of acne vulgaris.

The product is applied in addressing symptom clusters that may become intense or disruptive, related to managing symptoms of blemishes, skin redness, and visible irritations. It is used in situations involving certain distressing symptoms, such as the symptoms related to inflammatory or irritative states and symptoms that create noticeable physiological strain on the skin.

Clearskin generally assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities. It contributes to easing the overall symptom load during episodes of heightened discomfort.

“Contributes to improved day-to-day comfort during symptomatic periods.”

The topical application supports patients during these episodes and may help patients cope more steadily with symptom fluctuations associated with this common condition.

Quick Fact: Relief for symptoms related to physical discomfort and inflammatory states

Regulatory References

  1. NIH DailyMed Label for Clearskin

Eligibility and Restrictions for Use

Who can and cannot use Clearskin? — Official Eligibility Information

Regulatory documents establish specific rules regarding who may and who must not use Clearskin (which is generally based on the adapalene/benzoyl peroxide combination formulations). These rules are mandatory eligibility criteria.

Cannot Use (Contraindications and Exclusions)

Population Group Eligibility Status
Allergy/Hypersensitivity Contraindicated: Individuals with a known allergy to adapalene, benzoyl peroxide, or any other components in the formulation must not use the medicine.
Skin Condition at Site Excluded: The product must not be applied to areas of broken, cut, abraded, eczematous, or sunburned skin.
Pediatric Patients Excluded: Children younger than 9 or 12 years of age (depending on the specific product strength) are excluded, as safety and effectiveness have not been established.

Requires Special Consideration

Physiological State Regulatory Status
Pregnancy Caution: Use is generally recommended only if the potential benefit justifies the potential risk, as safety in pregnancy is not fully established.
Lactation (Breastfeeding) Caution: Caution is advised; use on the smallest possible area and avoid application to the nipple/areola area.

Eligibility is strictly defined by these criteria, meaning only patients meeting the required age limit and lacking any contraindicating allergies or skin conditions are eligible for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Clearskin, which contains Benzoyl Peroxide, is primarily defined by local pharmacodynamic effects, as regulatory documents indicate a low potential for systemic drug-drug interactions involving metabolic enzymes or transporters due to minimal percutaneous absorption.


Local Pharmacodynamic Interactions

Co-administration with other topical acne therapies that possess desquamative, irritant, or drying properties may result in an additive or cumulative irritant effect, which can sometimes be severe. Products cautioned against due to this effect include abrasive soaps, cleansers, and cosmetics with high concentrations of alcohol or astringents. This combination should generally be avoided.


Mandatory Timing Separation

Benzoyl Peroxide may reduce the efficacy of co-administered topical retinoids, such as Tretinoin, Isotretinoin, and Tazarotene, due to its oxidizing nature. Official regulatory guidance stipulates that if concurrent therapy is necessary, these products must be applied at different times of the day (e.g., separating the applications between morning and evening) to mitigate both chemical deactivation and local irritation.


Other Documented Restrictions

Specific interaction constraints exist for certain drug classes. Concurrent topical application with topical sulfone products (e.g., Dapsone) has been officially documented to cause a temporary yellow or orange discoloration of the skin or facial hair. Furthermore, some fixed-combination products containing Benzoyl Peroxide are officially restricted from co-administration with Erythromycin-containing medicines due to documented risks of antagonism.

Mechanism of Action

The compound's physiological action is driven by two simultaneous and complementary functions at the site of application: an oxidizing effect on bacteria and a keratolytic effect on follicular cells.

Non-Specific Microbial Eradication via Oxidation

This domain describes how the drug chemically modulates Cutibacterium acnes bacteria, the primary microbial target in the hair follicle. Benzoyl Peroxide decomposes to release Reactive Oxygen Species (ROS), which inflict rapid, non-selective oxidative damage to the bacterial cell structures. This action reduces the microbial population and limits the release of bacterial enzymes that produce irritating Free Fatty Acids (FFA), thereby modulating the initial inflammatory triggers within the pore.

Modulation of Follicular Cell Turnover (Keratolysis)

This domain focuses on the drug's effect on skin structure, where the generated ROS disrupt the cohesion of epithelial cells and keratin lining the follicle. This chemical breakdown promotes accelerated desquamation (shedding) of dead skin cells, which influences the regulation of follicular hyperkeratinization and the formation of the microcomedone (the initial pore blockage). By clearing the obstruction, the mechanism contributes to modulation of sebum flow dynamics and supports an open follicular unit.

Dosage and Administration Information

How Clearskin is Used: Official Administration Guidelines

Clearskin (Benzoyl Peroxide) is a topical medicine whose usage is guided by documentation detailing the appropriate route, schedule, and application method. The medication is available in strengths typically ranging from 2.5% to 10% as gels, creams, lotions, or washes, and is designated for external use only.


Dosing and Administration Schedule

Feature Official Regulatory Principle
Route of Administration Topical (Cutaneous) only.
Standard Starting Frequency Once daily application, after cleansing the skin.
Maintenance/Maximum Frequency Gradually increase to two or three times daily as needed or tolerated.
Application Rule Apply a thin layer to cover the entire affected area (not just spots).

Procedural Steps and Use Constraints

The usage protocol emphasizes specific preparation and handling steps as outlined in the official label:

  • Skin Preparation: The skin must be cleansed thoroughly and patted dry before the application of the product.
  • Initial Test: A sensitivity test is prescribed: apply the product sparingly to one or two small affected areas for the first three days to check for discomfort.
  • Response-Guided Adjustment: If excessive dryness or peeling occurs, the official instruction is to reduce the application frequency to once daily or every other day.
  • Age-Group Rule: The standard regimen applies to adults and children 12 years of age and over. Use in children younger than 12 years is not established in the product label.
  • Handling Restriction: Avoid contact with hair and colored fabrics (e.g., clothing or bedding), as the product can cause bleaching or discoloration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Clearskin

This section describes the types of studies that have examined the topical medicine Clearskin (Benzoyl Peroxide) and summarizes what the research has observed, focusing only on the structure of the evidence and areas where information remains uncertain.


Evidence for Use in Acne Vulgaris (Mild to Moderate Severity)

The initial regulatory assessment for this topical agent was based primarily on Randomized Controlled Trials (RCTs). These studies are part of the regulatory record, documenting how the agent was studied for its intended use under controlled conditions. Research focused on individuals diagnosed with mild to moderate acne vulgaris, a condition characterized by fluctuating or episodic manifestations.

In these trials, researchers primarily studied for changes in the overall condition. Outcomes related to physical discomfort was monitored by measuring specific data points, such as Acne Lesion Counts (counting inflammatory and non-inflammatory spots). The studies also evaluated the overall severity of the condition using tools like the Investigator's Global Assessment (IGA) score. Findings describe patterns observed in the studies during the defined observation periods.


Study Designs and Comparisons

The research record includes numerous studies where Clearskin was evaluated in settings that compare it to other treatments or to a vehicle. A vehicle is an inactive cream or gel that serves as a placebo comparator in many trials. Systematic Reviews and Meta-analyses were studied for by regulatory bodies to combine and analyze the results from many individual studies, helping to contextualize how patients reported their experience and how symptoms evolved in the observed populations.

These analyses research examined differences in measured data points, such as lesion counts, when the medicine was observed in comparison to the inactive vehicle. Systematic reviews have cited that comparative evidence remains limited for certain head-to-head comparisons against all standard topical agents.


Evidence in Different Patient Populations

The research has explored the agent’s use across different age groups, primarily focusing on Adolescents (age 12 and older) and Adults with mild to moderate acne severity. Studies monitored patients in these groups to see how symptoms evolved in the observed populations. Specific research has also examined populations with antibiotic-resistant bacterial strains. These studies were relevant in trials assessing short-term symptom patterns.


Research Gaps and Areas of Uncertainty

The majority of pivotal studies that form the core evidence base are limited to intermediate-term follow-up, typically ranging from 8 to 12 weeks. Long-term effects are not fully established. Evidence for long-term data extending past six months is often gathered from fewer trials or found within the aggregated data of systematic reviews. Major systematic reviews have cited trial heterogeneity as a key limitation, meaning the studies often differed significantly in their design, patient selection, and measurement techniques. This variation means that findings were mixed across studies.

Key Studies & References

  1. A systematic review of benzoyl peroxide monotherapy for the treatment of acne vulgaris
  2. Benzoyl Peroxide Topical Drug Monograph (DailyMed - NIH)
  3. WHO Model List of Essential Medicines (EML) - Benzoyl peroxide entry

Frequently Asked Questions (FAQ)

Common questions about Clearskin (FAQ)


Q: What conditions, other than acne, is Clearskin approved to treat?

The primary use of this medicine is for mitigating conditions leading to acne vulgaris. However, regulatory-aligned information notes that it is also used in the treatment of rosacea.

Q: What is the difference between Clearskin and over-the-counter acne products?

The active ingredient in Clearskin is Benzoyl Peroxide, which is frequently classified as an Over-the-Counter (OTC) product in different regions. The World Health Organization has also included this compound on its essential medicines list, confirming its recognized therapeutic importance globally.

Q: How is the effect of Clearskin different from an oral antibiotic?

Studies supported by regulatory bodies describe a distinguishing property of the compound’s mechanism of action. Because it relies on free radical generation, its antiseptic activity is recognized as being effective even against antibiotic-resistant bacterial strains.

Q: Why is Clearskin only available by prescription?

The active component of Clearskin, Benzoyl Peroxide, is available in the marketplace under two different classifications. Regulatory documents confirm that it is supplied as both an Over-the-Counter (OTC) product and a Human Prescription Drug, often in various topical forms and strengths.

Q: Does Clearskin affect the skin's natural oil production?

The official documentation describes the medicine's mechanism as helping to regulate skin structure by influencing follicular hyperkeratinization, which is the buildup of skin cells inside the pore. This action helps clear the obstruction and contributes to the modulation of sebum flow dynamics. Sebum is the skin's natural oil.

Q: How long does it typically take to see a noticeable change when using Clearskin?

According to official product information, clinically visible improvement in the condition being treated will normally occur by the third week of therapy. Maximum benefits may take longer to establish, and the treatment schedule often requires continuing use.

Q: Is it normal for acne to temporarily worsen right after starting Clearskin treatment?

Official safety information notes that very common local adverse effects, such as redness, burning, and dryness, tend to be more likely and peak during the first few weeks of treatment. These reactions may lessen as use continues, reflecting the skin's adjustment to the compound.

Q: What is the typical full course duration for Clearskin treatment, as described in studies?

Maximum effectiveness, often measured by lesion reduction, is expected after approximately eight to twelve weeks of use. Official information states that continuing use of the medicine is normally required beyond this point to maintain a satisfactory response.

Q: What evidence is there that Clearskin offers long-lasting results after stopping treatment?

The core evidence base for this medicine consists primarily of studies with intermediate-term follow-up, usually ranging from 8 to 12 weeks. Regulatory summaries indicate that long-term effects extending past six months are not fully established in the pivotal studies.

Q: Does Clearskin need to be used continuously, or is it only for a set period of time?

Official product information states that continuing use of the medicine is normally required to maintain a satisfactory clinical response. The medicine is often used as an adjunct in treatment regimens to help manage the underlying conditions.

Q: What is the typical percentage of patients who see clear skin after one course, according to research?

Regulatory-supported research generally describes efficacy using objective measurements, such as lesion reduction counts, rather than a specific 'clear skin percentage.' Studies have documented a mean reduction in total lesions from baseline of approximately 57% to 62% after 8 to 12 weeks of use in observed populations.

Q: Can taking Clearskin affect the overall effectiveness of other prescription medications?

According to regulatory documents, the potential for Clearskin to interact with systemic prescription medications (medicines taken orally or injected) is considered low. This is because the medicine is applied topically and has minimal percutaneous absorption, meaning very little enters the bloodstream to interact with internal systems.

Q: Is it safe to use other topical acne creams like Benzoyl Peroxide with Clearskin?

Official information notes that caution is advised when using Clearskin alongside other topical acne medicines. Products that are known to have desquamative (peeling), drying, or irritant properties may cause an additive or cumulative irritant effect if used at the same time. Separating the application times of certain topical medications is sometimes stipulated in regulatory guidance to reduce this risk.

Q: Does Clearskin have any known interactions with popular herbal products?

Official information states there is limited safety information for herbal remedies when used alongside this medicine. Herbal products are not typically tested for specific drug interactions with topical agents.

Q: How might Clearskin interact with specific supplements or high-dose vitamins?

Regulatory-aligned sources state there is limited safety information available for concurrent use with vitamins or other supplements. These types of products are often not studied in clinical trials for specific interactions with the topical medicine.

Q: Are there any restrictions on consuming alcohol while taking Clearskin?

Official information indicates that, in the context of systemic drug-drug interactions, it is generally acceptable to consume alcohol while using topical Benzoyl Peroxide.

Q: Are there any known dietary restrictions mentioned in the patient information for Clearskin?

Official information indicates that there are no specific food or drink restrictions required while using topical Benzoyl Peroxide.

Q: Does sun exposure while on Clearskin increase the chance of long-term skin discoloration?

The official product information includes a warning that use of the medicine may increase sensitivity to sunlight. Regulatory information notes that excessive sun exposure should be avoided while using the product. Additionally, regulatory documents note that applying Clearskin concurrently with certain topical sulfone products may temporarily cause a yellow or orange discoloration of the skin or facial hair.

Q: Is it safe to undergo waxing or laser hair removal procedures while taking Clearskin?

The medicine may cause skin irritation, peeling, and dryness, which are factors often considered before undergoing physical procedures. Official warnings also note that contact with hair should be avoided due to the potential for bleaching or discoloration.

Q: Is it necessary to pause other parts of a standard skincare routine when starting Clearskin?

Official regulatory information cautions that some components of a standard routine may increase local irritation. Specifically, using Clearskin alongside abrasive soaps, cleansers, or cosmetics with high alcohol or astringent concentrations may lead to an additive irritant effect, and concurrent use with Clearskin is generally discouraged in official information.

Q: Can Clearskin be used by people with a history of eczema or severe dry skin?

The medicine is excluded from application on skin that is currently broken, cut, abraded, sunburned, or eczematous. It is also important to note that dry skin is listed in official documents as a very common adverse reaction, meaning it affects many individuals using the product.

Q: Are there any specific pre-existing medical conditions that may affect eligibility for Clearskin?

Official eligibility criteria state that the medicine is contraindicated (must not be used) if a person has a known hypersensitivity to any of the product’s components, or if the skin at the site is broken or eczematous. Regulatory-aligned information suggests other cautions may apply to patients with a history of lung or breathing disease.

Q: What does the term 'teratogenic' mean in the official warnings for Clearskin?

The product is assigned a Pregnancy Category C classification. This classification is assigned when animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans to confirm the risk.

Q: What official risk management or surveillance programs exist for Clearskin use?

The risks associated with use in specific populations, particularly women who can become pregnant, are managed through official regulatory criteria. This includes requiring special consideration and the use of caution in prescribing and monitoring.

Q: Can Clearskin still be prescribed to a person who has previously completed a full course of the medicine?

Official information indicates that continuing use of the medicine is normally required to maintain a satisfactory clinical response, even after the initial clearing of lesions. Because the medicine is often used as an adjunct in various regimens, use over extended periods or repeated courses is common practice.

Q: Are there any known issues with Clearskin use in older adult populations?

Clinical trial data for a Benzoyl Peroxide product observed no overall differences in safety or effectiveness between subjects aged 65 and over and younger subjects in the study population.

How should Clearskin be stored and disposed of?

How to Store and Dispose of Clearskin? — Official Regulatory Information


Storage & Handling Requirements

Condition Requirement
Temperature Store at mathbf20 C to mathbf25 C (Controlled Room Temperature); excursions permitted between mathbf15 C and mathbf30 C.
Protection Keep in the original, tightly closed container and protect from light, moisture, and excessive heat.
Safety Keep the medication and its container out of the reach of children and pets.

Disposal Instructions

Unused or expired medication should primarily be disposed of using an official mathbfdrug take-back program. If a take-back option is not immediately available, the medication must be prepared for disposal in household trash: mix the capsules (without crushing) with an mathbfundesirable substance like dirt or used coffee grounds, place the mixture in a mathbfsealed container, and then discard. Do not flush this medicine down the toilet or sink. Always scratch out personal information on the label before discarding the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clearskin found in:

A-Z Index: